Regulatory & Legal

After flawless human trials, a Chapel Hill startup secures funding to bring its revolutionary ultrasound-based blood clot treatment to the United States.

Despite a crippling storm, the D.C. Auto Show thrived, highlighting local culture, national policy debates, and a surprising pivot in the auto industry.

A multi-year deal for Iron Dome parts highlights a strategic shift, validating Nukkleus' focus on the defense industry's vital Tier-2 suppliers.

As fraudulent hospice claims top $3 billion, a new private certification program hopes to restore trust and protect vulnerable end-of-life patients.

Gartner recognizes ETQ for its visionary QMS platform as the industry tackles supply chain risks and embraces data-driven, automated quality management.

UK insurers face a tight deadline for tough new PRA collateral rules. A new solution from Transcend aims to ease the burden and enhance risk oversight.

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

A new report reveals AI-powered disinformation is bypassing firewalls, costing billions. Experts say firms are dangerously unprepared for this new reality.

Eli Lilly partners with China's Zonsen PepLib, betting on its novel peptide platforms to fuel the next wave of therapies in oncology and metabolism.

A new partnership aims to slash waste and streamline clinical trials, heralding a tech-driven transformation in the backbone of drug development.

The rehab therapy software giant capped a pivotal year with key AI partnerships, a new executive team, and a major push into remote care, signaling its next era.

An independent analysis shows a specialized OB/GYN staffing model improves maternal outcomes, lowers C-section rates, and delivers a significant return on investment.

Colonial Heights schools adopt AI gun detection to boost safety, but the tech faces scrutiny over its real-world effectiveness and privacy implications.

With 144% customer growth, Maestra's all-in-one AI platform is luring brands from established players, sparking a tech stack consolidation debate.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

At a critical juncture, Abcourt Mines brings a long-time consultant in-house, betting his expertise can overcome financial hurdles and unlock project value.

A new report reveals a major shift in hospital spending, with tech and infrastructure costs now rising faster than drugs for the first time in a decade.